Azitra, Inc. (@azitrainc) 's Twitter Profile
Azitra, Inc.

@azitrainc

Precision dermatology powered by microbial and genetic engineering
Developing novel therapeutics to treat adverse skin conditions and disease

ID: 4164192988

linkhttp://www.azitrainc.com calendar_today11-11-2015 13:43:30

415 Tweet

534 Takipçi

381 Takip Edilen

Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference - more details available here $AZTR ir.azitrainc.com/news-releases/…

Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

Last week we announced that the first patient had been dosed in our Ph1/2 Trial for our ATR-04 Program targeting #oncology patients with #EGFRiRash. For more info on the trial - Check out this article from CancerNetwork® cancernetwork.com/view/advancing…

Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

Reminder that Azitra, Inc. Cofounder and Chief Operating Officer, Travis Whitfill PhD MPH, delivered a virtual presentation at the H.C. Wainwright 27th Annual Global Investment Conference Registration info: journey.ct.events/view/d825c56c-… #biotech #HCWainwright #PrecisionDerm

Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

We recently announced the 1st patient dosed in our Phase 1/2 trial for the ATR-04 program targeting oncology Patients with EGFRi associated rash. Learn more about our approach - engineering microbes for microbial #DrugDelivery for #PrecisionDermatology – azitrainc.com/technology/#pr…

We recently announced the 1st patient dosed in our Phase 1/2 trial for the ATR-04 program targeting oncology Patients with EGFRi associated rash. Learn more about our approach - engineering microbes for microbial #DrugDelivery for #PrecisionDermatology – 
azitrainc.com/technology/#pr…
Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

Throwing it back to a recent #podcast interview our CEO Francisco Salva did with #EmpoweredPatient Addressing the Skin Microbiome with Topical Engineered Microbes Available here podcasts.apple.com/us/podcast/add…

Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

Azitra, Inc. - Developing a broad pipeline of precision dermatology products. Learn about our #pipeline here azitrainc.com/pipeline/ #biotech #NethertonSyndrome #EGFRirash #Dermatology #PrecisionDerm #IchthyosisVulgaris

<a href="/azitrainc/">Azitra, Inc.</a>  - Developing a broad pipeline of precision dermatology products. Learn about our #pipeline here azitrainc.com/pipeline/ #biotech #NethertonSyndrome #EGFRirash #Dermatology #PrecisionDerm #IchthyosisVulgaris
Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

About us: Azitra, Inc. is leveraging microbial & protein engineering to solve the challenges of skin diseases through 3 strategies: -Proprietary microbial library -Engineering microbes for drug delivery -Advance genetic engineering Learn more: azitrainc.com/technology/ $AZTR

About us: <a href="/azitrainc/">Azitra, Inc.</a> is leveraging microbial &amp; protein engineering to solve the challenges of skin diseases through 3 strategies:
-Proprietary microbial library
-Engineering microbes for drug delivery
-Advance genetic engineering
Learn more:
azitrainc.com/technology/
$AZTR
Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

Azitra, Inc. to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit - #biotech #RareDisease #Dermatology #PrecisionDerm Maxim Group LLC $AZTR prnewswire.com/news-releases/…

Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

Yesterday's announcement in case you missed it - Azitra, Inc. to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit - #biotech #RareDisease #Dermatology #PrecisionDerm Maxim Group LLC $AZTR More info here: ir.azitrainc.com/news-releases/…

Yesterday's announcement in case you missed it -

<a href="/azitrainc/">Azitra, Inc.</a> to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit - #biotech #RareDisease #Dermatology #PrecisionDerm <a href="/MaximGrp/">Maxim Group LLC</a> $AZTR

More info here:
ir.azitrainc.com/news-releases/…
Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris ir.azitrainc.com/news-releases/… Data to be presented at BIO-Europe! #biotech #RareDisease #Derm #Dermatology #PrecisionDerm #IchthyosisVulgaris #BIOEurope $AZTR

Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

Great coverage in Dermatology Times highlighting our ATR-01 program in ichthyosis vulgaris! dermatologytimes.com/view/azitra-s-… #biotech #RareDisease #Derm #IchthyosisVulgaris #BIOEurope $AZTR

Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

Last week, we announced positive preclinical progress for our ATR-01 ichthyosis vulgaris program. For more info about this rare skin condition, see the Foundation for Ichthyosis and Related Skin Types (FIRST) firstskinfoundation.org/types-of-ichth… #RareDisease #Dermatology #IchthyosisVulgaris

Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

More from our most recent announcement. Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris. Read the release here: ir.azitrainc.com/news-releases/… #RareDisease #Dermatology #IchthyosisVulgaris $AZTR

Travis Whitfill (@twhitfill) 's Twitter Profile Photo

There are reports circulating around Azitra with respect to issuance of stock by the company. These reports are false. Please refer to our IR page for official press releases and more information: ir.azitrainc.com $AZTR

Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates #biotech #PrecisionMedicine #PrecisionDerm #ClinicalTrials #NethertonSyndrome #EGFRiRash #CancerRash #IchthyosisVulgaris ir.azitrainc.com/news-releases/…

<a href="/azitrainc/">Azitra, Inc.</a> Announces Q3 2025 Results and Provides Business Updates #biotech #PrecisionMedicine #PrecisionDerm #ClinicalTrials #NethertonSyndrome #EGFRiRash #CancerRash #IchthyosisVulgaris ir.azitrainc.com/news-releases/…
Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

We recently announced positive preclinical data for our ATR-01 program, designed to treat #IchthyosisVulgaris - Check out our latest corp presentation - ir.azitrainc.com/static-files/8… #RareDisease #Dermatology #PrecisionDerm #biotech $AZTR

We recently announced positive preclinical data for our 
ATR-01 program, designed to treat #IchthyosisVulgaris - Check out our latest corp presentation - ir.azitrainc.com/static-files/8…
 #RareDisease #Dermatology #PrecisionDerm #biotech $AZTR
Azitra, Inc. (@azitrainc) 's Twitter Profile Photo

More about ATR-01 - A topical filaggrin protein for ichthyosis vulgaris ATR-01 delivers missing filaggrin protein to result in restoration of the skin barrier and skin hydration More info here: azitrainc.com/pipeline/#ATR-…

More about ATR-01 - A topical filaggrin protein for ichthyosis vulgaris

ATR-01 delivers missing filaggrin protein to result in restoration of the skin barrier and skin hydration

More info here: azitrainc.com/pipeline/#ATR-…